Kymera Therapeutics (KYMR)

• Market cap: $1.66B
• 1 day: -6.83%
• 5 days: -19.30%
• 1 month: -15.48%
• 3 months: -37.64%
• 6 months: -45.24%
• Year to date: -37.64%
• 1 year: -35.31%
• 5 years: -23.33%
• 10 years: -23.33%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

326% more call options, than puts

Call options by funds: $3M | Put options by funds: $704K

18% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 28

14% more funds holding in top 10

Funds holding in top 10: 7 [Q3] → 8 (+1) [Q4]

2% more funds holding

Funds holding: 175 [Q3] → 178 (+3) [Q4]

1.66% more ownership

Funds ownership: 108.38% [Q3] → 110.04% (+1.66%) [Q4]

5% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 58

12% less capital invested

Capital invested by funds: $3.27B [Q3] → $2.87B (-$404M) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $52 104% upside
• Avg. target: $57 125% upside
• High target: $60 135% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Citigroup Geoff Meacham 59% 1-year accuracy 20 / 34 met price target	104% upside $52	Buy Initiated	13 Mar 2025
HC Wainwright & Co. Andrew Fein 32% 1-year accuracy 113 / 358 met price target	135% upside $60	Buy Maintained	28 Feb 2025
Stephens & Co. Sudan Loganathan 22% 1-year accuracy 6 / 27 met price target	135% upside $60	Overweight Reiterated	21 Jan 2025